The Pulmonary Hypertension Treatment: Dogmas and Ghosts

Affiliations

¹ Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy; Department of Clinical Sciences and Community Medicine, University of Milan, Milan, Italy. Electronic address: Piergiuseppe.agostoni@unimi.it.
² Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.

Editorial

Piergiuseppe Agostoni et al. Am J Cardiol. 2023.

. 2023 Dec 1:208:201-202.

doi: 10.1016/j.amjcard.2023.08.185. Epub 2023 Sep 19.

¹ Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy; Department of Clinical Sciences and Community Medicine, University of Milan, Milan, Italy. Electronic address: Piergiuseppe.agostoni@unimi.it.
² Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.

No abstract available

Conflict of interest statement

Declaration of Competing Interest The authors have no competing interests to declare.

Transition from Intravenous Epoprostenol to Treprostinil Due to Intolerable Side Effects in Patients With Pulmonary Arterial Hypertension.
Kikuchi H, Goda A, Takeuchi K, Inami T, Kohno T, Soejima K, Satoh T. Kikuchi H, et al. Am J Cardiol. 2023 Nov 1;206:31-34. doi: 10.1016/j.amjcard.2023.08.078. Epub 2023 Sep 8. Am J Cardiol. 2023. PMID: 37677880